Mitral Regurgitation Clinical Trials in Atlanta, Georgia

6 studies are recruiting for mitral regurgitation in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Cephea Early Feasibility Study

   The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Emory University Hospital, Atlanta, Georgia

   Locations

   22 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT05061004 on ClinicalTrials.gov

2. Abbott Cephea Mitral Valve Disease Registry

   The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of co…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Piedmont Heart Institute, Atlanta, Georgia

   Locations

   24 in total

   Run by

   Abbott Medical Devices

   See if you can join NCT07069673 on ClinicalTrials.gov

3. EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)

   The goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main questions it aims to an…

   Stage

   Not phased

   Ages

   21 and older

   Site

   Emory Midtown, Atlanta, Georgia

   Locations

   3 in total

   Run by

   Polares Medical SA

   See if you can join NCT07517588 on ClinicalTrials.gov

4. ATLAS (AltaValve) Pivotal Trial

   This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Wellstar Center for Cardiovascular Care, Atlanta, Georgia

   Locations

   58 in total

   Run by

   4C Medical Technologies, Inc.

   See if you can join NCT06465745 on ClinicalTrials.gov

5. The ENCIRCLE Trial

   This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Emory University, Atlanta, Georgia

   Locations

   68 in total

   Run by

   Edwards Lifesciences

   See if you can join NCT04153292 on ClinicalTrials.gov

6. An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System

   Study to evaluate the feasibility, safety and performance of the HighLife trans-septal Transcatheter Mitral Valve in patients with moderate-severe and severe mitral regurgitation who are at high risk for surgical treatment.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Piedmont Heart, Atlanta, Georgia

   Locations

   10 in total

   Run by

   HighLife SAS

   See if you can join NCT04029337 on ClinicalTrials.gov